Life science company focused on solving Duchenne muscular dystrophy

Share this video

Solid exists to advance treatments for patients with Duchenne muscular dystrophy

The innovative Solid model

Solid Biosciences is a life science company focused on solving Duchenne muscular dystrophy. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted by Duchenne muscular dystrophy, our mandate is simple yet comprehensive – attack the roots of the disease and improve daily life for patients. 

  • Disease Focused

  • Patient Centric

  • Holistic Approach

  • Collaboration

  • Center of Excellence

Developing therapies for Duchenne muscular dystrophy

Solid is building a portfolio of approaches with the potential to target the many facets of the disease.

View Our Pipeline

  • Gene Therapy

    Our gene therapy program has the potential to significantly slow or even halt the progression of the disease.

    Learn More

  • Disease Modifying Therapies

    We are examining small molecule and biologic candidates that may help manage the secondary disorders associated with Duchenne muscular dystrophy.

    Learn More

  • Assistive Devices

    We are developing assistive devices that may help patients perform everyday activities with greater ease.

    Learn More

More information about Solid?

Please subscribe to receive our latest news